{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:02:23Z","timestamp":1793160143036,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/CRTF\/21\/24251"],"award-info":[{"award-number":["FS\/CRTF\/21\/24251"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s10557-022-07397-x","type":"journal-article","created":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T07:02:38Z","timestamp":1666854158000},"page":"5-8","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Nicorandil \u2014 an Effective Multitarget Drug for Cardioprotection?"],"prefix":"10.1007","volume":"37","author":[{"given":"Lucie","family":"Pearce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek M.","family":"Yellon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5182-4980","authenticated-orcid":false,"given":"Sean M.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,27]]},"reference":[{"issue":"1","key":"7397_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jacc.2018.09.086","volume":"73","author":"SM Davidson","year":"2019","unstructured":"Davidson SM, Ferdinandy P, Andreadou I, et al. Multitarget strategies to reduce myocardial ischemia\/reperfusion injury: JACC review topic of the week. J Am Coll Cardiol. 2019;73(1):89\u201399.","journal-title":"J Am Coll Cardiol"},{"key":"7397_CR2","doi-asserted-by":"crossref","unstructured":"Kobara M, Amano T, Toba H, Nakata T. Nicorandil suppresses ischemia-induced norepinephrine release and ventricular arrhythmias in hypertrophic hearts. Cardiovasc Drugs Ther. 2022.","DOI":"10.1007\/s10557-022-07369-1"},{"issue":"18","key":"7397_CR3","doi-asserted-by":"publisher","first-page":"e026232","DOI":"10.1161\/JAHA.122.026232","volume":"11","author":"G Qian","year":"2022","unstructured":"Qian G, Zhang Y, Dong W, et al. Effects of nicorandil administration on infarct size in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the CHANGE trial. J Am Heart Assoc. 2022;11(18):e026232.","journal-title":"J Am Heart Assoc"},{"issue":"10124","key":"7397_CR4","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/S0140-6736(18)30316-7","volume":"391","author":"MEH Ong","year":"2018","unstructured":"Ong MEH, Perkins GD, Cariou A. Out-of-hospital cardiac arrest: prehospital management. Lancet. 2018;391(10124):980\u20138.","journal-title":"Lancet"},{"issue":"1","key":"7397_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1023\/B:CARD.0000025751.82774.a9","volume":"18","author":"S Horinaka","year":"2004","unstructured":"Horinaka S, Kobayashi N, Yabe A, et al. Nicorandil protects against lethal ischemic ventricular arrhythmias and up-regulates endothelial nitric oxide synthase expression and sulfonylurea receptor 2 mRNA in conscious rats with acute myocardial infarction. Cardiovasc Drugs Ther. 2004;18(1):13\u201322.","journal-title":"Cardiovasc Drugs Ther"},{"key":"7397_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.dib.2017.07.033","volume":"14","author":"G Campo","year":"2017","unstructured":"Campo G, Pavasini R, Morciano G, et al. Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment elevation myocardial infarction treated with percutaneous coronary intervention. Data Brief. 2017;14:197\u2013205.","journal-title":"Data Brief"},{"issue":"9","key":"7397_CR7","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.amjcard.2006.12.034","volume":"99","author":"H Ishii","year":"2007","unstructured":"Ishii H, Ichimiya S, Kanashiro M, et al. Effect of intravenous nicorandil and preexisting angina pectoris on short- and long-term outcomes in patients with a first ST-segment elevation acute myocardial infarction. Am J Cardiol. 2007;99(9):1203\u20137.","journal-title":"Am J Cardiol"},{"issue":"9597","key":"7397_CR8","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/S0140-6736(07)61634-1","volume":"370","author":"M Kitakaze","year":"2007","unstructured":"Kitakaze M, Asakura M, Kim J, et al. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials. Lancet. 2007;370(9597):1483\u201393.","journal-title":"Lancet"},{"key":"7397_CR9","doi-asserted-by":"crossref","unstructured":"Birnbaum Y, Ye R, Ye Y. Aspirin blocks the infarct-size limiting effect of ischemic postconditioning in the rat. Cardiovasc Drugs Ther. 2021.","DOI":"10.1007\/s10557-021-07241-8"},{"key":"7397_CR10","doi-asserted-by":"crossref","unstructured":"Ye R, Jneid H, Alam M et al. Do we really need aspirin loading for STEMI? Cardiovasc Drugs Ther. 2022.","DOI":"10.1007\/s10557-022-07327-x"},{"issue":"4","key":"7397_CR11","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s10557-016-6668-z","volume":"30","author":"JM Tarkin","year":"2016","unstructured":"Tarkin JM, Kaski JC. Vasodilator therapy: nitrates and nicorandil. Cardiovasc Drugs Ther. 2016;30(4):367\u201378.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"2","key":"7397_CR12","doi-asserted-by":"publisher","first-page":"H841","DOI":"10.1152\/ajpheart.00678.2003","volume":"287","author":"DJ Hausenloy","year":"2004","unstructured":"Hausenloy DJ, Yellon DM, Mani-Babu S, Duchen MR. Preconditioning protects by inhibiting the mitochondrial permeability transition. Am J Physiol Heart Circ Physiol. 2004;287(2):H841\u20139.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"7397_CR13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/00005344-199801000-00011","volume":"31","author":"J Imagawa","year":"1998","unstructured":"Imagawa J, Baxter GF, Yellon DM. Myocardial protection afforded by nicorandil and ischaemic preconditioning in a rabbit infarct model in vivo. J Cardiovasc Pharmacol. 1998;31(1):74\u20139.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"7397_CR14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00395-017-0662-x","volume":"113","author":"X Rossello","year":"2018","unstructured":"Rossello X, Yellon DM. The RISK pathway and beyond. Basic Res Cardiol. 2018;113(1):2.","journal-title":"Basic Res Cardiol"},{"issue":"17","key":"7397_CR15","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1177\/15353702211013444","volume":"246","author":"F Chen","year":"2021","unstructured":"Chen F, Chen ZQ, Zhong GL, Zhu JJ. Nicorandil inhibits TLR4\/MyD88\/NF-\u03baB\/NLRP3 signaling pathway to reduce pyroptosis in rats with myocardial infarction. Exp Biol Med (Maywood). 2021;246(17):1938\u201347.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"4","key":"7397_CR16","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/BF00788520","volume":"92","author":"CS Carr","year":"1997","unstructured":"Carr CS, Yellon DM. Ischaemic preconditioning may abolish the protection afforded by ATP-sensitive potassium channel openers in isolated human atrial muscle. Basic Res Cardiol. 1997;92(4):252\u201360.","journal-title":"Basic Res Cardiol"},{"key":"7397_CR17","doi-asserted-by":"crossref","unstructured":"IONA Study Group. Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial. Lancet 359(9314):1269\u201375.","DOI":"10.1016\/S0140-6736(02)08265-X"},{"issue":"1","key":"7397_CR18","first-page":"2","volume":"20","author":"A Dana","year":"1999","unstructured":"Dana A, Yellon DM. ATP dependent K+ channel: a novel therapeutic target in unstable angina. Eur Heart J. 1999;20(1):2\u20135.","journal-title":"Eur Heart J"},{"issue":"6","key":"7397_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00395-019-0756-8","volume":"114","author":"G Heusch","year":"2019","unstructured":"Heusch G. Coronary microvascular obstruction: the new frontier in cardioprotection. Basic Res Cardiol. 2019;114(6):45.","journal-title":"Basic Res Cardiol"},{"key":"7397_CR20","doi-asserted-by":"crossref","unstructured":"Bonfig NL, Soukup CR, Shah AA et al. Increasing myocardial edema is associated with greater microvascular obstruction in ST-segment elevation myocardial infarction. Am J Physiol Heart Circ Physiol. 2022;323(4):H818\u201324.","DOI":"10.1152\/ajpheart.00347.2022"},{"issue":"4","key":"7397_CR21","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/0002-9149(95)80029-R","volume":"75","author":"M Hongo","year":"1995","unstructured":"Hongo M, Takenaka H, Uchikawa S, Nakatsuka T, Watanabe N, Sekiguchi M. Coronary microvascular response to intracoronary administration of nicorandil. Am J Cardiol. 1995;75(4):246\u201350.","journal-title":"Am J Cardiol"},{"key":"7397_CR22","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.15420\/ecr.2019.20","volume":"15","author":"A Hubert","year":"2020","unstructured":"Hubert A, Seitz A, Pereyra VM, Bekeredjian R, Sechtem U, Ong P. Coronary artery spasm: the interplay between endothelial dysfunction and vascular smooth muscle cell hyperreactivity. Eur Cardiol. 2020;15:e12.","journal-title":"Eur Cardiol"},{"issue":"24","key":"7397_CR23","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1093\/eurheartj\/ehw136","volume":"37","author":"SA Nazir","year":"2016","unstructured":"Nazir SA, McCann GP, Greenwood JP, et al. Strategies to attenuate micro-vascular obstruction during P-PCI: the randomized reperfusion facilitated by local adjunctive therapy in ST-elevation myocardial infarction trial. Eur Heart J. 2016;37(24):1910\u20139.","journal-title":"Eur Heart J"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-022-07397-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-022-07397-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-022-07397-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T09:14:12Z","timestamp":1673428452000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-022-07397-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,27]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["7397"],"URL":"https:\/\/doi.org\/10.1007\/s10557-022-07397-x","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,27]]},"assertion":[{"value":"20 October 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}